S&P 500

Johnson & Johnson (JNJ) — 10-Year DCF Projection Model

Free stock research tool. Build a 10-year revenue, earnings (EPS), and free cash flow forecast for Johnson & Johnson (JNJ) stock, a company in the Health Care (Pharmaceuticals) sector. Pulls audited SEC EDGAR XBRL financials, triangulates Wall Street analyst consensus across Yahoo Finance, NASDAQ, and StockAnalysis, and overlays AI-clustered news + social event probabilities directly onto projected EPS. For equity research — not personal budgeting or accounting.

Build JNJ projection model →Browse all stocks

Johnson & Johnson at a glance

Ticker
JNJ
Company
Johnson & Johnson
Sector
Health Care
Sub-industry
Pharmaceuticals
Headquarters
New Brunswick, New Jersey
Founded
1886
Added to S&P 500
1973-06-30
Index membership
S&P 500

What you'll see in your JNJ model

  • 10 years of audited historical financials for Johnson & Johnson, sourced directly from the SEC's EDGAR XBRL filings (10-K and 10-Q).
  • Triangulated Wall Street consensus for JNJ's forward revenue, EBITDA, and EPS across Yahoo Finance, NASDAQ, and StockAnalysis with cross-source dispersion (σ).
  • AI Event Factors: top-10 news/social themes for JNJ with probability sliders and live EPS impact.
  • Sensitivity tables and Excel export for every assumption.

About Johnson & Johnson

Johnson & Johnson (NYSE/NASDAQ: JNJ) was founded in 1886 and is headquartered in New Brunswick, New Jersey. The company operates in the Health Care sector (Pharmaceuticals sub-industry) and is a constituent of the S&P 500. Our projection model builds a clean discounted-cash-flow view of Johnson & Johnson in roughly five seconds and lets you adjust every assumption to test your own thesis.